Wagener, N., Macher-Göppinger, S., Pritsch, M., Hüsing, J., Hoppe-Seyler, K., Schirmacher, P., . . . Hohenfellner, M. (2010). Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma. BMC cancer, 10, . https://doi.org/10.1186/1471-2407-10-524
Chicago-Zitierstil (17. Ausg.)Wagener, Nina, et al. "Enhancer of Zeste Homolog 2 (EZH2) Expression Is an Independent Prognostic Factor in Renal Cell Carcinoma." BMC Cancer 10 (2010). https://doi.org/10.1186/1471-2407-10-524.
MLA-Zitierstil (9. Ausg.)Wagener, Nina, et al. "Enhancer of Zeste Homolog 2 (EZH2) Expression Is an Independent Prognostic Factor in Renal Cell Carcinoma." BMC Cancer, vol. 10, 2010, https://doi.org/10.1186/1471-2407-10-524.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.